Kacila Mirsad, Schäfer Katrin, Subasić Esad, Granov Nermir, Omerbasić Edin, Kucukalić Faida, Selimović-Mujcić Ermina
Heart Center Sarajevo, University of Sarajevo Clinics Center, Bosnia and Herzegovina.
Bosn J Basic Med Sci. 2006 Aug;6(3):48-53. doi: 10.17305/bjbms.2006.3144.
The aim of this study is to compare the effects of colloidal cardioplegia and blood cardioplegia in patients who underwent cardiac surgical procedures with cardiopulmonary bypass, and to evaluate their influence on hemodilution, bleeding and consumption of donor blood products in a retrospective clinical study. 100 male patients who underwent cardiac surgical procedure were divided into two groups: 50 patients were administered intermittent normotherm or mild hypotherm (34 degrees C) Calafiore blood cardioplegia with potassium chloride 14,9%; 50 patients were administered one initial doses of cold Kirsch - solution followed from intermittent cold colloidal cardioplegia using hydroxyethyl starch (HES 450/0,7). Hemoglobin values after the first dose of cardioplegia were significantly lower in the HES-group than in the Calafiore- group). After the first dose of cardioplegia platelets count was lower in the HES-group than in the Calafiore-group. Hemoglobin and hematocrit values 24h postoperative were lower in the HES-group than in the Calafiore-group. There was no difference in chest-drainage bleeding 12h and 24h postoperative between the groups. The consumption of donor erythrocyte concentrate and fresh frozen plasma was significantly higher in the HES-than in the Calafiore- group. The choice of either colloidal or blood cardioplegia does not influence the postoperative chest-drainage bleeding. The results suggest that high molecular colloidal cardioplegia with HES-solution is associated with higher hemodilution during and after cardiopulmonary bypass and significantly increases the consumption of donor blood products.
本研究旨在比较胶体心脏停搏液和血液心脏停搏液在接受体外循环心脏手术患者中的效果,并在一项回顾性临床研究中评估它们对血液稀释、出血及供体血液制品消耗的影响。100例行心脏手术的男性患者被分为两组:50例患者接受间歇性常温或轻度低温(34℃)含14.9%氯化钾的卡拉菲奥雷血液心脏停搏液;50例患者先给予一剂冷基尔希溶液,随后使用羟乙基淀粉(HES 450/0.7)进行间歇性冷胶体心脏停搏液灌注。胶体组在首次给予心脏停搏液后的血红蛋白值显著低于卡拉菲奥雷组。胶体组在首次给予心脏停搏液后的血小板计数低于卡拉菲奥雷组。术后24小时胶体组的血红蛋白和血细胞比容值低于卡拉菲奥雷组。两组术后12小时和24小时的胸腔引流出血量无差异。胶体组供体红细胞浓缩液和新鲜冰冻血浆的消耗量显著高于卡拉菲奥雷组。选择胶体心脏停搏液或血液心脏停搏液均不影响术后胸腔引流出血。结果表明,使用HES溶液的高分子胶体心脏停搏液与体外循环期间及之后更高的血液稀释相关,并显著增加供体血液制品的消耗量。